title: Plasma membrane proteomics and its application in clinical cancer biomarker discovery.
abstract: Plasma membrane proteins that are exposed on the cell surface have important biological functions, such as signaling into and out of the cells, ion transport, and cell-cell and cell-matrix interactions. The expression level of many of the plasma membrane proteins involved in these key functions is altered on cancer cells, and these proteins may also be subject to post-translational modification, such as altered phosphorylation and glycosylation. Additional protein alterations on cancer cells confer metastatic capacities, and some of these cell surface proteins have already been successfully targeted by protein drugs, such as human antibodies, that have enhanced survival of several groups of cancer patients. The combination of novel analytical approaches and subcellular fractionation procedures has made it possible to study the plasma membrane proteome in more detail, which will elucidate cancer biology, particularly metastasis, and guide future development of novel drug targets. The technical advances in plasma membrane proteomics and the consequent biological revelations will be discussed herein. Many of the advances have been made using cancer cell lines, but because the main goal of this research is to improve individualized treatment and increase cancer patient survival, further development is crucial to direct analysis of clinically relevant patient samples. These efforts include optimized specimen handling and preparation as well as improved proteomics platforms. Identification of potentially useful proteomics-based biomarkers must be validated in larger, well defined retrospective and prospective clinical studies, and these combined efforts should result in identification of biomarkers that will greatly improve early detection, prognosis, and prediction of treatment response.
authors.affiliation: Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, JB Winsløwsvej 25.3, 5000 Odense C, Denmark.
authors.forename: Rikke
authors.initials: R
authors.lastname: Leth-Larsen
authors.forename: Rikke R
authors.initials: RR
authors.lastname: Lund
authors.forename: Henrik J
authors.initials: HJ
authors.lastname: Ditzel
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D002462:Cell Membrane / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D008565:Membrane Proteins / Q000737:chemistry / Q000378:metabolism*; D009369:Neoplasms / Q000175:diagnosis / Q000378:metabolism*; D011499:Protein Processing, Post-Translational; D020543:Proteome / Q000378:metabolism*; D040901:Proteomics / Q000379:methods*
chemical_list: D014408:Biomarkers, Tumor; D008565:Membrane Proteins; D020543:Proteome
references.citation: Proteomics. 2008 Oct;8(19):4054-65
references.pmid: 18780347
references.citation: Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4377s-4383s
references.pmid: 16857814
references.citation: J Proteome Res. 2008 May;7(5):1904-15
references.pmid: 18410138
references.citation: Am J Pathol. 2004 Mar;164(3):831-40
references.pmid: 14982837
references.citation: Fundam Clin Pharmacol. 2008 Feb;22(1):1-18
references.pmid: 18251718
references.citation: Mol Cell Proteomics. 2009 Jun;8(6):1278-94
references.pmid: 19329653
references.citation: Ann Surg Oncol. 2004 Oct;11(10):907-14
references.pmid: 15383419
references.citation: J Proteome Res. 2008 Apr;7(4):1403-11
references.pmid: 18311906
references.citation: J Proteome Res. 2009 Mar;8(3):1358-67
references.pmid: 19178301
references.citation: Int J Cancer. 2008 Dec 15;123(12):2856-64
references.pmid: 18798264
references.citation: Lab Invest. 2007 Sep;87(9):851-7
references.pmid: 17632542
references.citation: Cancer Res. 2005 Jun 1;65(11):4645-52
references.pmid: 15930282
references.citation: J Immunol. 2006 Mar 1;176(5):2833-43
references.pmid: 16493040
references.citation: Mol Cell Proteomics. 2002 Nov;1(11):845-67
references.pmid: 12488461
references.citation: Mol Cell Proteomics. 2006 Dec;5(12):2319-25
references.pmid: 16943187
references.citation: Oncogene. 2009 Feb 12;28(6):803-14
references.pmid: 19060928
references.citation: J Chromatogr A. 2005 Apr 8;1070(1-2):57-64
references.pmid: 15861788
references.citation: Nat Genet. 2002 Dec;32 Suppl:526-32
references.pmid: 12454649
references.citation: Anal Chem. 2008 Jul 15;80(14):5286-92
references.pmid: 18558770
references.citation: Breast Cancer Res Treat. 2004 Feb;83(3):249-89
references.pmid: 14758095
references.citation: Nat Rev Cancer. 2005 Aug;5(8):615-25
references.pmid: 16034368
references.citation: Nat Biotechnol. 2005 May;23(5):617-21
references.pmid: 15834404
references.citation: Cancer. 2006 Nov 15;107(10):2337-45
references.pmid: 17048231
references.citation: Cancer. 2007 Aug 1;110(3):509-17
references.pmid: 17559147
references.citation: Proteomics. 2008 Oct;8(19):4146-55
references.pmid: 18763708
references.citation: Nat Rev Drug Discov. 2005 Jun;4(6):477-88
references.pmid: 15931257
references.citation: Proteomics. 2007 Aug;7(16):3010-29
references.pmid: 17654460
references.citation: Electrophoresis. 2002 Dec;23(24):4142-56
references.pmid: 12481271
references.citation: Mol Cell Proteomics. 2006 Jan;5(1):68-78
references.pmid: 16216825
references.citation: Proteomics. 2010 Feb;10(4):611-27
references.pmid: 19834916
references.citation: J Chromatogr A. 1996 Jan 12;720(1-2):119-26
references.pmid: 8601188
references.citation: Mol Cell Proteomics. 2006 Oct;5(10):1957-67
references.pmid: 16760258
references.citation: Annu Rev Biochem. 1972;41:731-52
references.pmid: 4263713
references.citation: Biochim Biophys Acta. 2006 Dec;1766(2):230-41
references.pmid: 16889898
references.citation: Mol Cell Proteomics. 2007 Oct;6(10):1778-87
references.pmid: 17623646
references.citation: Glycoconj J. 1997 Aug;14(5):569-76
references.pmid: 9298689
references.citation: Am J Clin Pathol. 2009 Dec;132(6):899-905
references.pmid: 19926582
references.citation: J Proteome Res. 2009 Aug;8(8):3808-15
references.pmid: 19537829
references.citation: Cancer Treat Rev. 2009 Jun;35(4):354-63
references.pmid: 19269105
references.citation: J Proteome Res. 2009 Jun;8(6):3078-90
references.pmid: 19341246
references.citation: Eur J Cancer. 2007 Mar;43(5):835-44
references.pmid: 17321128
references.citation: Mol Cell Proteomics. 2009 Aug;8(8):1988-98
references.pmid: 19467989
references.citation: Nat Rev Cancer. 2004 May;4(5):361-70
references.pmid: 15122207
references.citation: J Proteome Res. 2009 Feb;8(2):643-50
references.pmid: 19099503
references.citation: Genome Biol. 2006;7(8):R73
references.pmid: 16901351
references.citation: Hum Pathol. 2009 Oct;40(10):1418-26
references.pmid: 19428047
references.citation: Nat Protoc. 2006;1(2):1029-43
references.pmid: 17406340
references.citation: Expert Rev Proteomics. 2005 Jan;2(1):87-101
references.pmid: 15966855
references.citation: Anal Chem. 2005 Feb 1;77(3):886-94
references.pmid: 15679358
references.citation: Ann N Y Acad Sci. 1999 Jun 30;878:212-27
references.pmid: 10415733
references.citation: Biotechniques. 2006 Jun;40(6):790-8
references.pmid: 16774123
references.citation: Mol Cell Proteomics. 2005 Apr;4(4):492-522
references.pmid: 15695426
references.citation: J Proteome Res. 2002 Jul-Aug;1(4):351-60
references.pmid: 12645891
references.citation: Int J Biol Markers. 2006 Jul-Sep;21(3):131-40
references.pmid: 17013794
references.citation: Nat Rev Cancer. 2007 Feb;7(2):79-94
references.pmid: 17251915
references.citation: Neoplasia. 2008 Sep;10(9):1014-20
references.pmid: 18714363
references.citation: Glycobiology. 2009 Aug;19(8):899-909
references.pmid: 19433864
references.citation: Nat Rev Cancer. 2007 Sep;7(9):659-72
references.pmid: 17721431
references.citation: J Proteome Res. 2007 Sep;6(9):3491-500
references.pmid: 17663576
references.citation: Mol Cell Proteomics. 2009 Jul;8(7):1453-74
references.pmid: 19297561
references.citation: Expert Rev Proteomics. 2009 Apr;6(2):115-8
references.pmid: 19385938
references.citation: Proteomics. 2008 Aug;8(16):3263-73
references.pmid: 18690645
references.citation: Lancet. 2005 May 14-20;365(9472):1687-717
references.pmid: 15894097
references.citation: Brief Funct Genomic Proteomic. 2009 Mar;8(2):136-44
references.pmid: 19151093
references.citation: Nat Rev Mol Cell Biol. 2006 Dec;7(12):952-8
references.pmid: 17139335
references.citation: Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):779-84
references.pmid: 15642945
references.citation: J Proteome Res. 2006 Nov;5(11):2996-3007
references.pmid: 17081051
references.citation: Clin Transl Oncol. 2009 Jun;11(6):356-62
references.pmid: 19531450
references.citation: J Proteome Res. 2009 Feb;8(2):583-94
references.pmid: 19086899
references.citation: J Proteome Res. 2009 Aug;8(8):4151-60
references.pmid: 19522481
references.citation: Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14889-94
references.pmid: 17001009
references.citation: FEBS Lett. 2009 Jun 5;583(11):1728-35
references.pmid: 19328791
references.citation: Am Fam Physician. 2003 Sep 15;68(6):1075-82
references.pmid: 14524394
references.citation: Breast Cancer Res Treat. 2009 May;115(1):77-85
references.pmid: 18521745
references.citation: Clin Cancer Res. 2007 Aug 1;13(15 Pt 2):s4652-4
references.pmid: 17671159
references.citation: Nat Rev Mol Cell Biol. 2006 Jun;7(6):391-403
references.pmid: 16723975
references.citation: Nat Clin Pract Oncol. 2004 Dec;1(2):104-11
references.pmid: 16264828
references.citation: J Proteome Res. 2006 Oct;5(10):2632-41
references.pmid: 17022634
references.citation: Clin Cancer Res. 2007 Apr 1;13(7):1979-86
references.pmid: 17404077
references.citation: Cell. 2000 Oct 13;103(2):211-25
references.pmid: 11057895
references.citation: Nat Rev Cancer. 2004 Jan;4(1):45-60
references.pmid: 14681689
references.citation: Mol Cell Proteomics. 2008 Apr;7(4):661-71
references.pmid: 18039691
references.citation: BJU Int. 2008 Mar;101(6):675-83
references.pmid: 17941930
references.citation: Nature. 2008 Apr 3;452(7187):571-9
references.pmid: 18385731
references.citation: Mol Cell Proteomics. 2009 Aug;8(8):1959-71
references.pmid: 19457934
references.citation: Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5860-5
references.pmid: 17389395
references.citation: Methods Mol Biol. 2008;484:263-76
references.pmid: 18592185
references.citation: Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6940-5
references.pmid: 12771378
references.citation: J Clin Oncol. 2001 Jul 15;19(14):3376-84
references.pmid: 11454885
references.citation: J Invest Dermatol. 2001 Nov;117(5):1255-60
references.pmid: 11710941
references.citation: Biochemistry (Mosc). 2008 Nov;73(11):1200-6
references.pmid: 19120023
references.citation: Mol Cell Proteomics. 2009 Jun;8(6):1436-49
references.pmid: 19321434
references.citation: Oncogene. 2007 Jan 4;26(1):65-76
references.pmid: 16799640
references.citation: Eur J Cancer. 2007 Mar;43(5):828-34
references.pmid: 17329097
references.citation: Proteomics. 2008 Nov;8(21):4370-82
references.pmid: 18814326
references.citation: J Proteome Res. 2008 Apr;7(4):1419-26
references.pmid: 18303830
references.citation: Curr Protoc Protein Sci. 2001 May;Chapter 13:Unit13.1
references.pmid: 18429113
references.citation: Mol Cell Proteomics. 2005 Nov;4(11):1741-53
references.pmid: 16091476
references.citation: Nat Rev Cancer. 2002 Feb;2(2):91-100
references.pmid: 12635172
references.citation: Anal Chem. 2001 Jul 1;73(13):2836-42
references.pmid: 11467524
references.citation: J Proteome Res. 2005 Nov-Dec;4(6):2148-53
references.pmid: 16335961
references.citation: Virchows Arch. 2008 Dec;453(6):537-43
references.pmid: 18958494
references.citation: J Pharm Biomed Anal. 2007 Feb 19;43(3):1086-93
references.pmid: 17085005
references.citation: Cancer Metastasis Rev. 2008 Mar;27(1):5-10
references.pmid: 18066649
references.citation: Clin Chem. 2008 Jul;54(7):1166-75
references.pmid: 18487288
references.citation: Mol Cell Proteomics. 2007 Jan;6(1):43-55
references.pmid: 16847285
references.citation: J Proteome Res. 2005 Nov-Dec;4(6):1952-60
references.pmid: 16335939
references.citation: Mol Cell Proteomics. 2005 Apr;4(4):402-8
references.pmid: 15684408
references.citation: J Hepatol. 2009 Mar;50(3):592-603
references.pmid: 19157620
references.citation: Mol Cell Proteomics. 2004 Dec;3(12):1154-69
references.pmid: 15385600
references.citation: Dis Markers. 2008;25(4-5):207-18
references.pmid: 19126965
references.citation: Cell. 2007 Aug 10;130(3):395-8
references.pmid: 17693247
references.citation: J Pathol. 2003 Aug;200(5):620-6
references.pmid: 12898598
references.citation: J Proteome Res. 2009 Nov;8(11):5048-59
references.pmid: 19764822
references.citation: Clin Chem. 2006 Sep;52(9):1651-9
references.pmid: 16809399
references.citation: Mol Oncol. 2007 Sep;1(2):144-59
references.pmid: 18443658
references.citation: Glycoconj J. 2009 Feb;26(2):117-31
references.pmid: 18752066
references.citation: J Cancer Res Clin Oncol. 2008 Nov;134(11):1229-35
references.pmid: 18438684
references.citation: PLoS Pathog. 2006 Oct;2(10):e107
references.pmid: 17238276
references.citation: Nat Biotechnol. 1999 Oct;17(10):994-9
references.pmid: 10504701
references.citation: Stem Cells. 2005 Oct;23(9):1367-77
references.pmid: 16210410
references.citation: J Lipid Res. 2009 Apr;50 Suppl:S323-8
references.pmid: 18955730
references.citation: Proteomics. 2009 Apr;9(8):2118-30
references.pmid: 19337990
references.citation: Nature. 1975 Nov 6;258(5530):43-9
references.pmid: 1102991
references.citation: J Mol Biol. 2001 Jan 19;305(3):567-80
references.pmid: 11152613
references.citation: Int J Clin Oncol. 2008 Aug;13(4):308-13
references.pmid: 18704630
references.citation: Electrophoresis. 2005 Jan;26(2):297-319
references.pmid: 15657944
references.citation: Mol Cell Proteomics. 2004 Oct;3(10):1023-38
references.pmid: 15284337
references.citation: Lancet. 1998 May 16;351(9114):1451-67
references.pmid: 9605801
references.citation: J Proteome Res. 2008 Nov;7(11):4670-7
references.pmid: 18839982
references.citation: J Proteome Res. 2004 May-Jun;3(3):556-66
references.pmid: 15253437
references.citation: Clin Chem Lab Med. 2003 Dec;41(12):1562-70
references.pmid: 14708880
references.citation: J Proteome Res. 2006 May;5(5):1051-9
references.pmid: 16674093
references.citation: Genome Med. 2009 Jun 04;1(6):57
references.pmid: 19519948
references.citation: Mol Cell Proteomics. 2003 Nov;2(11):1198-204
references.pmid: 14506205
references.citation: BMC Cancer. 2006 Mar 16;6:68
references.pmid: 16542425
references.citation: Annu Rev Cell Dev Biol. 2004;20:839-66
references.pmid: 15473862
references.citation: Protein Sci. 1998 Apr;7(4):1029-38
references.pmid: 9568909
references.citation: Cell Mol Life Sci. 2006 Jun;63(12):1331-54
references.pmid: 16596337
references.citation: Proteomics. 2008 Aug;8(16):3284-93
references.pmid: 18646009
references.citation: J Proteome Res. 2010 Mar 5;9(3):1610-8
references.pmid: 20088484
references.citation: Nat Rev Cancer. 2002 Aug;2(8):563-72
references.pmid: 12154349
references.citation: Mol Cell Proteomics. 2009 Nov;8(11):2595-612
references.pmid: 19674965
references.citation: Proteomics. 2005 Aug;5(13):3262-77
references.pmid: 16052621
references.citation: Annu Rev Biophys Biomol Struct. 1993;22:145-71
references.pmid: 8347987
references.citation: Anal Bioanal Chem. 2009 Dec;395(8):2443-56
references.pmid: 19876624
references.citation: Mol Cell Biol. 2008 Aug;28(15):4896-914
references.pmid: 18505826
references.citation: J Proteome Res. 2007 Jul;6(7):2802-11
references.pmid: 17539671
references.citation: Mol Cell Proteomics. 2008 Apr;7(4):813-23
references.pmid: 18089551
references.citation: J Chromatogr A. 2005 Jun 3;1077(1):1-18
references.pmid: 15988981
references.citation: Clin Breast Cancer. 2003 Aug;4(3):203-9
references.pmid: 14499014
references.citation: Methods Mol Biol. 2008;428:43-53
references.pmid: 18287767
references.citation: Clin Cancer Res. 2008 Feb 15;14(4):1002-14
references.pmid: 18281532
references.citation: J Proteomics. 2009 Feb 15;72(1):12-22
references.pmid: 18926938
references.citation: J Biol Chem. 2008 Sep 26;283(39):26518-27
references.pmid: 18658134
references.citation: Nat Med. 2002 Nov;8(11):1323-7
references.pmid: 12389040
references.citation: J Mammary Gland Biol Neoplasia. 2001 Jul;6(3):355-64
references.pmid: 11547903
references.citation: Mol Cell Proteomics. 2008 Oct;7(10):1983-97
references.pmid: 18490355
references.citation: J Proteome Res. 2009 Jun;8(6):2656-66
references.pmid: 19441788
references.citation: Proteomics. 2009 Mar;9(6):1451-68
references.pmid: 19235172
references.citation: Mol Cell Proteomics. 2005 Jul;4(7):873-86
references.pmid: 15858219
references.citation: J Proteome Res. 2008 Aug;7(8):3304-13
references.pmid: 18578522
references.citation: Cancer. 2008 Sep 15;113(6):1294-301
references.pmid: 18661530
references.citation: J Proteome Res. 2008 May;7(5):1809-18
references.pmid: 18327898
references.citation: Biochim Biophys Acta. 1999 Dec 6;1473(1):4-8
references.pmid: 10580125
references.citation: Physiol Genomics. 2001 Apr 02;5(3):129-36
references.pmid: 11285366
references.citation: Nat Rev Cancer. 2005 Jul;5(7):526-42
references.pmid: 16069816
references.citation: Cancer Res. 2008 Jan 15;68(2):388-94
references.pmid: 18199532
references.citation: Anal Chem. 2004 Apr 1;76(7):1817-23
references.pmid: 15053638
references.citation: J Exp Bot. 2006;57(7):1501-8
references.pmid: 16574745
references.citation: Breast Cancer Res. 2008;10(5):R85
references.pmid: 18922159
references.citation: Analyst. 2008 Jun;133(6):731-8
references.pmid: 18493671
references.citation: Proteomics. 2008 May;8(10):1987-2005
references.pmid: 18491314
references.citation: Gastroenterology. 2005 Oct;129(4):1187-97
references.pmid: 16230073
references.citation: J Cell Mol Med. 2008 Jun;12(3):829-75
references.pmid: 18266954
references.citation: J Proteome Res. 2008 Oct;7(10):4313-25
references.pmid: 18729497
references.citation: J Proteomics. 2010 Jan 3;73(3):579-92
references.pmid: 19666151
references.citation: Proteomics. 2008 Aug;8(16):3236-56
references.pmid: 18651673